Clinical Trial Update: Relative Bioavailability Study of a Fixed-dose Combination Dolutegravir/Abacavir/Lamivudine Dispersible Tablet [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study of a fixed-dose combination dolutegravir/abacavir/lamivudine dispersible tablet has been completed. The trial evaluated t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• Lamivudine (lamivudine)
• abacavir (abacavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED